Works by Sakamoto, Junichi

Results: 246
    1
    2
    3

    A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).

    Published in:
    2016
    By:
    • Shoichi Hazama;
    • Hiromichi Maeda;
    • Shigeyoshi Iwamoto;
    • Ho Min Kim;
    • Hiroyoshi Takemoto;
    • Kenji Kobayashi;
    • Junichi Sakamoto;
    • Naoki Nagata;
    • Koji Oba;
    • Hideyuki Mishima;
    • Hazama, Shoichi;
    • Maeda, Hiromichi;
    • Iwamoto, Shigeyoshi;
    • Kim, Ho Min;
    • Takemoto, Hiroyoshi;
    • Kobayashi, Kenji;
    • Sakamoto, Junichi;
    • Nagata, Naoki;
    • Oba, Koji;
    • Mishima, Hideyuki
    Publication type:
    journal article
    4

    Impact of gastrectomy on efficacy and safety of second‐line chemotherapy patients with advanced gastric cancer: Exploratory analysis of two randomized phase III trials.

    Published in:
    Annals of Gastroenterological Surgery, 2025, v. 9, n. 3, p. 429, doi. 10.1002/ags3.12880
    By:
    • Nishikawa, Kazuhiro;
    • Koizumi, Wasaburo;
    • Tsuburaya, Akira;
    • Suzuki, Motoko;
    • Morita, Satoshi;
    • Fujitani, Kazumasa;
    • Akamaru, Yusuke;
    • Shimada, Ken;
    • Hosaka, Hisashi;
    • Nishimura, Ken;
    • Yoshikawa, Takaki;
    • Tsujinaka, Toshimasa;
    • Sakamoto, Junichi
    Publication type:
    Article
    5
    6

    A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1071, doi. 10.1007/s00280-009-0963-3
    By:
    • Yoshikawa, Takaki;
    • Tsuburaya, Akira;
    • Hirabayashi, Naoki;
    • Yoshida, Kazuhiro;
    • Nagata, Naoki;
    • Kodera, Yasuhiro;
    • Takahashi, Naoto;
    • Oba, Koji;
    • Kimura, Masayuki;
    • Ishikura, Satoshi;
    • Miyashita, Yumi;
    • Sakamoto, Junichi
    Publication type:
    Article
    7

    A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1103, doi. 10.1007/s00280-008-0693-y
    By:
    • Nakajo, Akihiro;
    • Hokita, Shuichi;
    • Ishigami, Sumiya;
    • Miyazono, Futoshi;
    • Etoh, Tadaaki;
    • Hamanoue, Masahiro;
    • Maenohara, Shigeho;
    • Iwashita, Toshimitsu;
    • Komatsu, Hideaki;
    • Satoh, Kiyoharu;
    • Aridome, Kuniaki;
    • Morita, Satoshi;
    • Natsugoe, Shoji;
    • Takiuchi, Hiroya;
    • Nakano, Shyuji;
    • Maehara, Yoshihiko;
    • Sakamoto, Junichi;
    • Aikou, Takashi;
    • Taxol, Kyushu
    Publication type:
    Article
    8
    9

    A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 2, p. 275, doi. 10.1007/s00280-007-0471-2
    By:
    • Kato, Takeshi;
    • Mishima, Hideyuki;
    • Ikenaga, Masakazu;
    • Murata, Kouhei;
    • Ishida, Hideyuki;
    • Fukunaga, Mutsumi;
    • Ota, Hirofumi;
    • Tominaga, Shusei;
    • Ohnishi, Tadashi;
    • Amano, Masahiro;
    • Ikeda, Kimimasa;
    • Ikeda, Masataka;
    • Sekimoto, Mitsugu;
    • Sakamoto, Junichi;
    • Monden, Morito
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    A multicenter non-randomized phase III study of sentinel node navigation surgery for early gastric cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 305, doi. 10.1093/jjco/hyaa179
    By:
    • Kamiya, Satoshi;
    • Takeuchi, Hiroya;
    • Fukuda, Kazumasa;
    • Kawakubo, Hirofumi;
    • Takahashi, Naoto;
    • Mitsumori, Norio;
    • Terashima, Masanori;
    • Tsujimoto, Hironori;
    • Kinami, Shinichi;
    • Natsugoe, Shoji;
    • Ohi, Masaki;
    • Kadoya, Shinichi;
    • Fushida, Sachio;
    • Hayashi, Hideki;
    • Nabeshima, Kazuhito;
    • Sakamoto, Junichi;
    • Matsuda, Satoru;
    • Mayanagi, Shuhei;
    • Irino, Tomoyuki;
    • Sato, Yasunori
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    A Phase I Study of Combination Therapy of the Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin Twice-a-week Administration (JFMC27-9902 Step2) in Patients with Advanced Gastric Cancer Using a Continual Reassessment Method.

    Published in:
    Japanese Journal of Clinical Oncology, 2007, v. 37, n. 12, p. 924, doi. 10.1093/jjco/hym124
    By:
    • Morita, Satoshi;
    • Nakata, Bunzo;
    • Tsuji, Akihito;
    • Mitachi, Yasushi;
    • Shirasaka, Tetsuhiko;
    • Saji, Shigetoyo;
    • Ohashi, Yasuo;
    • Sakamoto, Junichi;
    • Hirakawa, Kosei
    Publication type:
    Article
    31
    32
    33

    A Randomized Phase III trial of Post-operative Adjuvant Oral Fluoropyrimidine versus Sequential Paclitaxel/Oral Fluoropyrimidine; and UFT versus S1 for T3/T4 Gastric Carcinoma: The Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.

    Published in:
    Japanese Journal of Clinical Oncology, 2005, v. 35, n. 11, p. 672, doi. 10.1093/jjco/hyi179
    By:
    • Tsuburaya, Akira;
    • Sakamoto, Junichi;
    • Morita, Satoshi;
    • Kodera, Yasuhiro;
    • Kobayashi, Michiya;
    • Miyashita, Yumi;
    • Macdonald, John S.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease.

    Published in:
    Cancers, 2022, v. 14, n. 22, p. 5673, doi. 10.3390/cancers14225673
    By:
    • Kawakami, Hisato;
    • Nishikawa, Kazuhiro;
    • Shimokawa, Toshio;
    • Fujitani, Kazumasa;
    • Tamura, Shigeyuki;
    • Endo, Shunji;
    • Kobayashi, Michiya;
    • Kawada, Junji;
    • Kurokawa, Yukinori;
    • Tsuburaya, Akira;
    • Yoshikawa, Takaki;
    • Sakamoto, Junichi;
    • Satoh, Taroh
    Publication type:
    Article
    45
    46
    47

    Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.

    Published in:
    2019
    By:
    • Tomita, Naohiro;
    • Kunieda, Katsuyuki;
    • Maeda, Atsuyuki;
    • Hamada, Chikuma;
    • Yamanaka, Takeharu;
    • Sato, Toshihiko;
    • Yoshida, Kazuhiro;
    • Boku, Narikazu;
    • Nezu, Riichiro;
    • Yamaguchi, Shigeki;
    • Mishima, Hideyuki;
    • Sadahiro, Sotaro;
    • Muro, Kei;
    • Ishiguro, Megumi;
    • Sakamoto, Junichi;
    • Saji, Shigetoyo;
    • Maehara, Yoshihiko
    Publication type:
    journal article
    48

    Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).

    Published in:
    2022
    By:
    • Sadahiro, Sotaro;
    • Sakamoto, Kazuhiro;
    • Tsuchiya, Takashi;
    • Takahashi, Takao;
    • Ohge, Hiroki;
    • Sato, Toshihiko;
    • Kondo, Ken;
    • Ogata, Yutaka;
    • Baba, Hideo;
    • Itabashi, Michio;
    • Ikeda, Masataka;
    • Hamada, Madoka;
    • Maeda, Kiyoshi;
    • Masuko, Hiroyuki;
    • Takahashi, Keiichi;
    • Sakamoto, Junichi;
    • Kusano, Mitsuo;
    • Hyodo, Ichinosuke;
    • Taguri, Masataka;
    • Morita, Satoshi
    Publication type:
    journal article
    49
    50